Alopecia Areata Occurring after COVID-19 Vaccination: A Single-Center, Cross-Sectional Study

Medicine and Dentistry

• Alopecia Areata 100%
• Patient 81%
• COVID-19 45%
• Diseases 18%
• Age 18%
• Development 18%
• Systemic Therapy 18%
• Minoxidil 18%
• Therapeutic Procedure 18%
• Autoimmune Disease 9%
• Recurrent Disease 9%
• Vaccine 9%
• Topical Treatment 9%
• Differential Diagnosis 9%
• Diagnosis 9%
• Drug 9%
• Scalp 9%
• Corticosteroid 9%
• Cyclosporine 9%
• Alopecia Mucinosa 9%
• Chemotherapeutic Agent 9%
• Topical Corticosteroid 9%
• Male 9%
• Female 9%
• Hair 9%
• Cross Sectional Study 9%